Creation of Substitution Labile Pyrazolylborate Metal Complexes
取代不稳定的吡唑基硼酸盐金属配合物的制备
基本信息
- 批准号:09640675
- 负责人:
- 金额:$ 0.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) Bis[dihydrobis(3,5-bis(trifluoromethyl)pyrazolyl)borate]cobalt was prepared and the structure was determined by X ray crystallographic analysis. The cobalt center is coordinated to four pyrazolyl groups in a square planner manner and to two B-H groups at the axial positions forming totally a distorted octahedral configuration. This is in marked contrast to those of known non-substituted and 3, 5-dimethyl substituted pyrazolylborate derivatives which appear inn a tetrahedral configuration Similar nickel complex having a B-H-M agostic interaction was prepared.(2) Bis(triphenylphosphine)[dihydrobis(3,5-R_2-pyrazolyl)borate]ruthenium hydrides (R=H, Me, CF_3) were prepared and the structures containing a B-H-Ru agostic interaction were determined by X ray crystallography. Based on the reactivity with CO, strength of the agostic interaction was estimated to decrease in the order, Me> H * CF_3.(3) Bis(triphenylphosphine)[dihydrobis(3, 5-R_2-pyrazolyl)borate]rhodium complexes (R=H, Me, CF_3) were prepared and the structures were determined by X ray crystallographic analysis. The rhodium centers are coordinated in a square planner manner to the four pyrazolyl groups. No B-H-Rh agostic interactions were observed in these complexes.(4) eta^3-Allyl and indenyl[hydrotris(3,5-R_2-pyrazolyl)borate]palladium complexes (R=H, Me, CF_3) were prepared and the structures were determined by X ray crystallographic analysis. Their fluxional behavior in solution were studied by NMR spectroscopy.
(1)制备双[二氢双(3,5-双(三氟甲基)吡唑基)硼酸]钴并通过X射线晶体分析确定结构。钴中心以正方形平面方式与四个吡唑基配位,并在轴向位置与两个B-H基团配位,形成完全扭曲的八面体构型。这与以四面体构型出现的已知的未取代的和3,5-二甲基取代的吡唑基硼酸酯衍生物形成鲜明对比。制备了具有B-H-M激动相互作用的类似镍络合物。 (2)双(三苯基膦)[二氢双(3,制备了氢化5-R_2-吡唑基)硼酸酯]钌氢化物(R=H,Me,CF_3),其结构包含B-H-Ru 激动相互作用通过 X 射线晶体学测定。根据与 CO 的反应性,预计相互作用的强度按 Me> H * CF_3 的顺序降低。(3) 双(三苯基膦)[二氢双(3, 5-R_2-吡唑基)硼酸盐]铑配合物 (R制备了=H、Me、CF_3)并通过X射线晶体分析确定了结构。铑中心以方形平面方式与四个吡唑基配位。在这些配合物中没有观察到B-H-Rh的相互作用。(4)制备了eta^3-烯丙基和茚基[氢三(3,5-R_2-吡唑基)硼酸酯]钯配合物(R=H,Me,CF_3)并通过X射线晶体学分析确定结构。通过核磁共振波谱研究了它们在溶液中的流动行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMAZAKI Hiroshi其他文献
YAMAZAKI Hiroshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMAZAKI Hiroshi', 18)}}的其他基金
Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
培养胎盘细胞和人源化肝小鼠中人细胞色素 P450 3A 酶与沙利度胺、泊马度胺和来那度胺生物活性和毒性的相关性
- 批准号:
17K08425 - 财政年份:2017
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
口腔鳞癌分子靶向药物耐药机制及对策研究
- 批准号:
16K11732 - 财政年份:2016
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
口腔鳞状细胞癌分子靶向药物耐药性有效标志物的开发
- 批准号:
25463120 - 财政年份:2013
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
沙利度胺通过直接激活核受体 CAR 和 PXR 增加肝脏细胞色素 P450 活性和药物代谢
- 批准号:
23590200 - 财政年份:2011
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
evaluationofeffectivenessoftheobjectiveexaminationforautism indeafchildren
聋儿自闭症客观检查效果评价
- 批准号:
22791642 - 财政年份:2010
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Role of cancer stem cells related molecules in oral squamous cell carcinoma
肿瘤干细胞相关分子在口腔鳞癌中的作用
- 批准号:
22592246 - 财政年份:2010
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of chemical-induced toxicity in fetal livers
化学品致胎儿肝脏毒性的分子机制
- 批准号:
17390034 - 财政年份:2005
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
内分泌干扰物通过 AHR 诱导毒性表达的分子机制
- 批准号:
15390040 - 财政年份:2003
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on the separation of rac and meso isomers and the reactivity of group 4 bridged metallocene complexes
外消旋和内消旋异构体的分离及第4族桥联茂金属配合物的反应性研究
- 批准号:
11640544 - 财政年份:1999
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES
通过人体药物代谢酶预测药物分布
- 批准号:
11557191 - 财政年份:1999
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
New Catalysts for Cis-Selective Metathesis: Agostic Interaction and Meso-N-Heterocyclic Carbenes
顺式选择性复分解的新催化剂:不规则相互作用和内消旋-N-杂环卡宾
- 批准号:
0848560 - 财政年份:2009
- 资助金额:
$ 0.96万 - 项目类别:
Continuing Grant
ACTIVATION OF H-H,C-H,Si-H,AND C-C BONDS BY MEANS OF COORDINATIVELY UNSATURATED METAL SPECIES
通过配位不饱和金属物种激活 H-H、C-H、Si-H 和 C-C 键
- 批准号:
03453098 - 财政年份:1991
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
New Materials Starting from Organometallic Complexes
以有机金属配合物为原料的新材料
- 批准号:
01490012 - 财政年份:1989
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Preparation and Control of Coordinatively Unsaturated Active Species
配位不饱和活性物种的制备与控制
- 批准号:
63470078 - 财政年份:1988
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)